...
首页> 外文期刊>Molecular and Cellular Biology >Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression
【24h】

Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

机译:肝X受体/降压复合物在ABCA1和SREBP1基因表达调控中的启动子特异性作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Liver X receptors (LXRs) regulate the expression of genes involved in cholesterol and fatty acid homeostasis, including the genes for ATP-binding cassette transporter A1 (ABCA1) and sterol response element binding protein 1 (SREBP1). Loss of LXR leads to derepression of the ABCA1 gene in macrophages and the intestine, while the SREBP1c gene remains transcriptionally silent. Here we report that high-density-lipoprotein (HDL) cholesterol levels are increased in LXR-deficient mice, suggesting that derepression of ABCA1 and possibly other LXR target genes in selected tissues is sufficient to result in enhanced HDL biogenesis at the whole-body level. We provide several independent lines of evidence indicating that the repressive actions of LXRs are dependent on interactions with the nuclear receptor corepressor (NCoR) and the silencing mediator of retinoic acid and thyroid hormone receptors (SMRT). While dissociation of NCoR and SMRT results in derepression of the ABCA1 gene in macrophages, it is not sufficient for derepression of the SREBP1c gene. These findings reveal differential requirements for corepressors in the regulation of genes involved in cholesterol and fatty acid homeostasis and raise the possibility that these interactions may be exploited to develop synthetic ligands that selectively modulate LXR actions in vivo.
机译:肝X受体(LXR)调节涉及胆固醇和脂肪酸稳态的基因的表达,包括ATP结合盒转运蛋白A1(ABCA1)和固醇反应元件结合蛋白1(SREBP1)的基因。 LXR的丢失会导致巨噬细胞和肠中ABCA1基因的表达降低,而SREBP1c基因仍然在转录上保持沉默。在这里,我们报道在LXR缺陷型小鼠中高密度脂蛋白(HDL)胆固醇水平升高,这表明选定组织中ABCA1以及其他LXR靶基因的阻遏足以导致HDL生物发生在整个人体水平上的增强。我们提供了几条独立的证据,表明LXR的抑制作用取决于与核受体共加压子(NCoR)以及视黄酸和甲状腺激素受体(SMRT)的沉默介导剂的相互作用。虽然NCoR和SMRT的解离导致巨噬细胞中ABCA1基因的表达降低,但这不足以使SREBP1c基因表达降低。这些发现揭示了在涉及胆固醇和脂肪酸稳态的基因调控中,对于核心抑制剂的不同需求,并增加了利用这些相互作用来开发选择性调节体内LXR作用的合成配体的可能性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号